{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "PCTY",
  "name": "Paylocity Holding Corporation",
  "url": "https://frontierpicks.com/dossiers/PCTY/",
  "json_url": "https://frontierpicks.com/dossiers/PCTY.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": "MEDIUM",
  "archetype": {
    "code": "a3",
    "n": 3
  },
  "current_thesis": "Post-print re-rating leg: the 2026-08-04 Q4 FY26 beat ($1.84 adj. EPS vs $1.61 est.) triggered five price-target raises in 48 hours and a $150.42 close on 2026-08-07, +35.5% over three months. The buy is multiple recovery in mid-cap HCM software, paid for against an FY27 guide that steps recurring growth down from 12.2% to ~8%.",
  "invalidation_trigger": "A weekly close below $140 (fills the 2026-08-04 post-print gap and returns PCTY to its pre-earnings range); secondarily, any cut to the $1.777B FY27 recurring & other revenue floor at the Q1 FY27 print in late October.",
  "catalyst_date": null,
  "outcome": "PLAYED_OUT",
  "outcome_date": "2026-08-20",
  "invalidation_fired": false,
  "themes": [
    "ai-enterprise-software"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year ends June 30. \"Q1 FY27\" is the September quarter and is reported in late October, not the calendar-Q1 print.",
    "Client fund interest income (float on client payroll balances) is reported separately from recurring & other revenue and moves with front-end rates.",
    "From FY27 deferred contract costs amortize over 8 years instead of 7, worth ~120-140bp to FY27 Adjusted EBITDA margin. FY27 margins are not comparable to FY26.",
    "Revenue is partly per-employee-per-month, so client headcount changes flow into recurring revenue independent of new-logo wins.",
    "Director and >10% holder Steven Sarowitz sells under a Rule 10b5-1 plan adopted 2025-12-15; his August sales are pre-scheduled rather than discretionary.",
    "FY26 Form 10-K was filed 2026-08-05, one day after the Q4 release, so there is no separate late-August filing event."
  ],
  "body_markdown": "## Current Thesis\n\nThe post-print re-rating leg from the 2026-08-04 Q4 FY26 beat is still intact and has flattened. The stock closed $150.42 on 2026-08-07 and $153.34 on 2026-08-21, with RSI(14) easing from 71.1 to 66.6 over the same stretch — higher price, lower momentum reading. Sell-side is still marking up: TD Cowen went to $177 from $168 on 2026-08-20, its second raise in fifteen days. What an investor is buying here is the second half of a multiple recovery in mid-cap HCM software, against an FY27 guide that steps recurring growth from 12.2% down to roughly 8%, and with no company-dated event on the calendar — the FY26 Form 10-K was filed 2026-08-05, which cleared the last interim document ahead of the Q1 FY27 print in late October.\n\n## Bull Case\n\n- **The sell-side reset did not stop at the print.** TD Cowen raised to $177 from $168 with a Buy rating on 2026-08-20, after the 2026-08-05/06 wave: BTIG $180, KeyBanc $178, TD Cowen $168, Cantor Fitzgerald $165, Barclays $154. BMO Capital Markets is reported at $175 (Outperform, up from $143) in August 2026 coverage.\n- **FY26 10-K, filed 2026-08-05:** revenue $1.77B (+11% YoY), net income $269.74M (+18.8%), diluted GAAP EPS $4.92 (+22.4% from $4.02). Client base roughly 44,400, about +7% organic; annual revenue retention above 92%.\n- **Q4 FY26 beat, 2026-08-04:** total revenue $444.7M (+11.0% YoY), recurring & other revenue $415.6M (+12.4%), non-GAAP EPS $1.84 against $1.61 consensus.\n- **Q1 FY27 guidance came in over the estimate:** total revenue $439.5M–$444.5M versus $438.482M consensus; recurring & other revenue $414.0M–$419.0M, characterised by management as ~10% growth.\n- **FY27 profit guide sits above the FY26 actual:** Adjusted EBITDA $690.0M–$700.0M versus FY26's $654.9M (37.0% of total revenue); excluding client fund interest, $587.0M–$597.0M.\n- **Cash conversion and a shrinking share count:** FY26 operating cash flow $533.3M, free cash flow $427.8M, cash and equivalents $271.9M against $81.3M long-term debt; FY26 repurchases $398.1M / 2.8M shares, cumulative $697.8M / 4.6M shares since May 2024.\n- **The post-print gap has not been surrendered:** closes of $147.81 (2026-08-05), $150.42 (2026-08-07) and $153.34 (2026-08-21) sit above the pre-earnings range.\n\n## Bear Case\n\n- **The deceleration is contractual, not atmospheric.** FY27 recurring & other revenue is guided $1.777B–$1.792B (~8%) against FY26 actual $1.651B (+12.2%); FY27 total revenue $1.880B–$1.895B (~7%) against FY26's $1.771B (+11.0%).\n- **Total revenue is guided to grow slower than recurring revenue,** which puts client fund interest income — float on client payroll balances — on a declining path outside management's control.\n- **Roughly 120–140bp of the FY27 margin guide is a convention change:** from FY27 deferred contract costs amortize over 8 years rather than 7, disclosed 2026-08-04. FY27 Adjusted EBITDA margin is not comparable to FY26 on a like-for-like accounting.\n\n- **Price is now inside the sell-side band rather than beneath it.** MarketBeat's compilation cited in 2026-08-20 coverage shows a consensus average target of $160.53 with 12 Buy and 5 Hold ratings, versus the 2026-08-21 close of $153.34. Dispersion remains wide: UBS Neutral $128 on 2026-07-22 against BTIG $180.\n- **The trailing-quarter gain has stopped compounding.** The pipeline series shows a three-month price change of 35.7% as of 2026-08-21 versus 35.5% as of 2026-08-07 — inference: the measurement window rolled forward onto a higher starting point and the last two weeks added little.\n- **Overhead supply is unresolved:** the last close sits 15.9% under the $182.31 52-week high, and the ground between is held by prior owners.\n\n## Setup & Price Structure\n\n- Reference close $153.34 on 2026-08-21. 52-week high $182.31, leaving the stock 15.9% below it. Three-month price change of 35.7%. RSI(14) at 66.6.\n- Momentum reading has cooled while price rose: RSI 71.1 at the $150.42 close on 2026-08-07, 66.6 at $153.34 on 2026-08-21. Measured, not interpreted — participation in the leg is narrowing rather than broadening.\n- The structure to watch is the 2026-08-04 print gap. The first post-print close was $147.81 on 2026-08-05 (+3.1% on a 14.2% EPS beat, a muted reaction), and every close since has held above that shelf. The $140 area is where the gap fills and the stock re-enters its pre-earnings range.\n- Upside reference points are all third-party marks: the $160.53 consensus average, then the $165–$180 target cluster (Cantor $165, TD Cowen $177, KeyBanc $178, BTIG $180), then the $182.31 52-week high.\n- **Crowding observables.** Coverage clustering is analyst-action wire traffic (Benzinga, TipRanks, MarketBeat compilations) rather than retail-forum flow — this is not a message-board name. Seventeen rated sell-side opinions split 12 Buy / 5 Hold. Insider supply is plan-driven and continuous through August at $148–$156. The company itself repurchased $398.1M in FY26. There is no earnings date inside 30 days, so there is no print to compress positioning into.\n- **The narrative is maturing.** Attention peaked with the 2026-08-04 print and the 2026-08-05/06 target wave; the narrative is still working (TD Cowen's 2026-08-20 raise, price higher on 2026-08-21 than on 2026-08-07); flow is moderating (RSI 71.1 → 66.6, a two-week price gain of under three dollars, last close below the consensus average target). It is not saturated — the coverage is institutional and the stock remains 15.9% below its own 52-week high — and it is not accelerating, because the fresh-headline supply ended with the 10-K on 2026-08-05.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-09-04 (est.)** — August US employment situation (BLS). Paylocity bills partly per employee per month, so mid-market payroll counts feed recurring revenue with a lag; the ~8% FY27 recurring guide assumes a stable installed base.\n- **~2026-09-16 (est.)** — FOMC decision. Client fund interest income is already guided lower in FY27, and front-end rates determine how much of the $690M–$700M Adjusted EBITDA guide comes from float versus operations.\n- **~2026-10-29 (est.)** — Q1 FY27 earnings. Outside the 30-day window and the only company-specific binary between now and then.\n\n## Elapsed catalysts\n\n- **No company-dated event inside the window.** The FY26 Form 10-K (fiscal year ended 2026-06-30) was filed 2026-08-05; the estimated late-August filing date carried in earlier coverage has come and gone. *(passed 21d ago)*\n\n## What Would Change Our Mind\n\nThe thing that has to hold is the 2026-08-04 print gap and the $147.81–$150.42 shelf built on top of it; losing that returns the stock to the range it traded in before the beat, and the re-rating argument goes with it. Concretely, a weekly close below $140 fills the gap and ends the leg. Ahead of that, a sustained set of daily closes back under the $147 area would say the post-print shelf failed as support.\n\nOn fundamentals, the read breaks if Q1 FY27 recurring & other revenue prints below the guided $414.0M floor in late October, or if the FY27 recurring range is cut below $1.777B. Two operating markers from the 2026-08-04 call would flag it earlier: average revenue per client falling sequentially from ~$37,200, or revenue retention slipping below the 92% level management has cited. A downgrade cycle — the same shops that moved to $165–$180 in August cutting back toward the UBS $128 mark — would show the sell-side leg reversing.\n\nWhat would strengthen the case instead: weekly closes established above the $160.53 consensus average with the momentum reading holding, which would mean the market is pricing the FY27 guide as an opening bid rather than a ceiling.\n\n## Correlation Notes\n\n- Moves with the mid-market HCM complex — PAYC, PAYX, ADP — and with the broader mid-cap SaaS multiple. A peer's guidance on mid-market wins reads directly onto Paylocity's ~7% client-count growth.\n- Carries two-sided rate exposure that pure software peers do not: falling front-end rates compress client fund interest income (a revenue line) while typically supporting software multiples. The offset happens inside the same ticker, so a rate-cut headline is not a clean directional input.\n- Employment-linked. Per-employee-per-month billing means US mid-market payroll counts move recurring revenue independent of new-logo wins, which gives the name labor-cycle beta on top of software beta.\n- Fiscal calendar is offset from the peer group: fiscal year ends June 30, so what the company calls Q1 FY27 is the September quarter and lands in late October.",
  "first_seen": "2026-07-28",
  "last_analyzed": "2026-08-22T09:58:38+00:00",
  "last_synthesized": "2026-08-22",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}